 |
 |

Malignant Lymphoma Associated With Hydantoin Drugs
James J. Anthony
Arch Neurol. 1970;22(5):450-454.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
LYMPHADENOPATHY has been recognized as one of the less common side effects of the hydantoin drugs1-3 for more than a quarter of a century. These drugs have been available for the treatment of epilepsy since 1938. Lymphadenopathy in these patients had been considered a hypersensitivity reaction because of the frequent occurrence of eosinophilia, and benign since it disappeared with discontinuation of the hydantoin. There is a dearth of knowledge about the mechanism of hydantoin lymphadenopathy.
The benignancy of this lymphadenopathy has been questioned.4-6 Great difficulty has been encountered in the differentiation between "benign" and malignant lymphoid reactions in general.4 Hyman and Sommers7 reported six cases of lymphoma in association with hydantoin therapy.
A study was undertaken with the hope of clarifying the relationship between hydantoin therapy and malignant lymphoma. A review of the literature was processed, and then a retrospective study of necropsies undertaken to
. . . [Full Text PDF of this Article]
Author Affiliations
Cincinnati
From the Department of Neurology, University of Cincinnati College of Medicine and the Cincinnati General Hospital, Cincinnati. Mr. Anthony is a senior medical student at the University of Cincinnati College of Medicine.
Footnotes
Submitted for publication Aug 25, 1969; accepted Oct 20.
Reprint requests to Department of Neurology, Cincinnati General Hospital, Cincinnati 45229 (Mr. Anthony).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|